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INTRODUCTION
Along with the rising tide of  the current epidemic of  
diabetes in India,[1,2] the prevalence ofgestational diabetes 
mellitus (GDM) is also rising in India.[3] However, the 
diagnosis of  GDM has always been beset with problems 
related to differing diagnostic criteria with confl icting 
evidence regarding the maternal and fetal outcomes.[4]
Till recently, the GDM diagnostic criteria proposed by 
World Health Organization (WHO)[5] or the American 
Diabetes Association (ADA)[6] were followed in most 
countries. Though the WHO recommendation was not 
based on studies with maternal and fetal outcomes, the 2-h 
cut-off  value of140 mg/dl for diagnosis of  GDM was 
found to predict the neonatal outcomes in a fairly robust 
manner.[7-11] Recently, the International Association of  
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A B S T R A C T
Aim: We aimed to compare the International Association of Diabetes and Pregnancy Study Groups (IADPSG) and the World Health 
Organization (WHO) criteria to diagnose gestational diabetes mellitus (GDM) in Chennai, India. Materials and Methods: We reviewed 
the retrospective data of 1351 pregnant women who underwent screening for GDM at four selected diabetes centers at Chennai (three 
private and one government). All women underwent an oral glucose tolerance test using 75g glucose load and fasting, 1-h, and 2-h 
samples were collected. The IADPSG and WHO criteria were compared for diagnosis of GDM. Results: A total of 839 women had GDM 
by either the IADPSG or the WHO criteria, of whom the IADPSG criteria identifi ed 699 and the WHO criteria also identifi ed 699 women 
as having GDM. However, only 599/839 women (66.6%) were identifi ed by both criteria. Thus, 140/839 women (16.7%) were missed 
by both the IADPSG and the WHO criteria. 687/699 (98.2%) of the women with GDM were identifi ed by the WHO criteria. In contrast, 
each value of IADPSG criteria i.e., fasting, 1 h, and 2 h identifi ed only 12.5%, 14%, and 22%, respectively. Conclusions: A single 
WHO cut-point of 2 h140 mg/dl appears to be suitable for large-scale screening for GDM in India and other developing countries.
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Diabetes and pregnancy study groups (IADPSG) based on 
the hyperglycemia and adverse pregnancy outcome study 
has introduced new GDM criteria in an attempt to unify 
the GDM criteria throughout the world.[12] The IADPSG 
criteria require three samples i.e., fasting, 1 h, and 2 h after 
75 g glucose, whereas the WHO criteria need two samples 
namely the fasting and 2 h, although in practice, only the 
2 h is used.[13] In this paper, we have applied the WHO and 
the IADPSG cut-off  values and compared the two criteria 
with respect to their impact on diagnosing GDM among 
pregnant women seen at four diabetic clinics in Chennai 
city in Southern India.
MATERIALS AND METHODS
We reviewed the retrospective data of  1351 pregnant 
women who underwent screening for GDM at four 
selected diabetes centers at Chennai (three private and 
one government). At diabetes centers, pregnant women 
with a high index of  suspension with elevated glucose 
levels are referred for a confi rmation of  GDM. Hence, 
the prevalence of  GDM at such center would be very 
high and hence they do not refl ect the prevalence of  
GDM in the community. All women underwent an oral 
glucose tolerance test (OGTT) using 75 g glucose load 
and fasting, 1-h, and 2-h samples were collected. The 
IADPSG and WHO criteria were compared for diagnosis 
of  GDM. According to the IADPSG criteria, any one of  
the following criteria was used for diagnosis of  GDM, 
i.e., fasting92 mg/dl (5.1 mmol/L), 1 h180 mg/dl 
(10.0 mmol/L), or 2 h153 mg/dl (8.5 mmol/L). According 
to the WHO criteria, either fasting126 mg/dl (7.0 mmol/L) 
or 2-h value140 mg/dl (7.8 mmol/L) was classifi ed as 
GDM.
RESULTS
Out of  a total of  1351 pregnant women who underwent 
screening for GDM at four diabetes clinics in Chennai, 
839 women were diagnosed to have GDM either by the 
IADPSG or by the WHO criteria.
The IADPSG criteria identifi ed 699/839 (83.3%) of  the 
total number of  women classifi ed as GDM. The WHO 
criteria, again, identifi ed 699/839 (83.3%) of  the total 
number of  women with GDM. However, as shown in 
the Venn diagram [Figure 1], only 559 women of  the total 
839 women with GDM (66.6%) were identifi ed by both 
the IADPSG and WHO criteria. Thus, 140/839 (16.7%) 
of  the GDM women would have been missed if  IADPSG 
criteria alone were used. Conversely, 140/839 (16.6%) of  
the GDM women would have been missed if  WHO criteria 
alone was used.
We next compared the usefulness of  the WHO 2-h criteria 
alone in comparison to the full WHO criteria namely 2 h and 
fasting WHO criteria and the results are shown in Table 1. 
Use of  the WHO 2-h criteria was found to identify 687/699 
(98.2%) of  the GDM cases identifi ed by the full WHO criteria.
Table 1 also compares the percentage of  GDM women 
identifi ed by the fasting, 1 h and 2 h IADPSG compared 
to the full IADPSG criteria i.e., any 1 elevated value.
It can be seen that in contrast to the 2-h WHO criteria where 
one value could pick up the majority (98%) of  GDM cases, 
each value of  the IADPSG criteria identifi ed much lower 
percentages of  GDM cases compared to using all three 
values. Using the IADPSG criteria, the fasting value alone 
identifi ed 12.5%, 1-h alone identifi ed 14% and the 2-h alone 
identifi ed 22% cases and using any two values identifi ed only 
51% of  the GDM cases. Hence, it is clear that all three values 
are needed to identify GDM cases by the IADPSG criteria.
Of  the 88 women with fasting value alone elevated 
according to the IADPSG criteria, only 30 (34%) were 
Table 1: Comparison of the components of the 
international association of diabetes and pregnancy 
study groups and world health organization criteria to 
identify gestational diabetes mellitus
Criteria (n=839)
IADPSG (%) WHO (%)
Only fasting value elevated 88 (12.5) 0 (0)
Only 1 h value elevated 98 (14) Not applicable
Only 2 h value elevated 154 (22) 687 (98.3)
Any 2 value elevated
(either fasting+1 h
or fasting+2 h or 1 h+2 h)
359 (51) 12 (1.7)
Any value elevated 699 (100) 699 (100)
IADPSG: International association of diabetes and pregnancy study groups, 
WHO: World health organization
Figure 1: Venn diagram showing the gestational diabetes cases identifi ed 
by both international association of diabetes and pregnancy study Groups 
and World Health Organization criteria and by either criteria
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picked up by WHO 2-h value. Among the 98 individuals 
who had elevated 1-h value on IADPSG, only 47 (48%) 
were picked up by WHO 2-h value.
Comparing the 2-h cut-points of  140 mg/dl (WHO) and 
153 mg/dl (IADPSG), it is seen that 113 women had a 2-h 
cut-point between 140 and 153 mg/dl. These 113 would 
have been missed using the higher 2-h IADPSG cut-point.
DISCUSSION
This study shows that the number of  GDM cases identifi ed 
at four selected diabetes centers in Chennai is the same by 
WHO criteria and the IADPSG criteria. However, only 
66.6% of  the GDM cases identifi ed by the WHO and 
IADPSG criteria are the same individuals, whereas 16.7% 
each of  the GDM women identifi ed by IADPSG and 
WHO criteria are different individuals.
The WHO fi rst proposed criteria for GDM using a 75 g 
OGTT in the 1980s.[14,15] In its technical report published 
in 1994, it defined GDM as diabetes mellitus (DM) 
first recognized during pregnancy, and gestational 
impaired glucose tolerance (GIGT) as impaired glucose 
tolerance (IGT) fi rst recognized during pregnancy.[16] In 
1998, WHO recommended new criteria.[5,17] With regard 
to GDM, pregnant women who met the WHO criteria for 
DM or IGT were classifi ed as having GDM and, therefore, 
the term GIGT disappeared. Some studies have been 
published takingfasting plasma glucose (FPG) 126 mg/dl 
as the criteria for GDM.[18] However, the more recent 
studies have altogether ignored the FPG criteria and have 
used only the 2-h140 mg/dl criteria of  the WHO.[3,13] 
When the ADA lowered the FPG to 100 mg/dl from the 
previous 110 mg/dl for diagnosis of  impaired fasting 
glucose in non-pregnant adults, the FPG level of  126 mg/dl 
in pregnancy started looking too high and most people just 
chose to ignore the FPG level for the diagnosis of  GDM. 
However, till date, there is no offi cial recommendation 
from WHO to drop FPG criteria and to follow only the 
2-h value of  140 mg/dl.
It appears an anomaly that in the WHO criteria, the fasting 
cut-off  had been set at 126 mg/dl which is diagnostic of  
diabetes in non-pregnant adults, whereas the 2-h cut-off  
was set at 140 mg/dl, which is the diagnostic cut-point 
for IGT in non-pregnant adults. Probably because of  
this inherent contradiction in the diagnostic criteria, the 
fasting values in the WHO criteria are not particularly 
useful to diagnose GDM and this might explain why the 
WHO 2-h value alone picked up over 98% of  all cases 
diagnosed by both fasting and 2-h WHO criteria in this 
study. Another point to be noted is that if  a pregnant 
woman has a FPG 126 mg/dl, it is considered overt 
diabetes complicating pregnancy, and not as GDM, by the 
IADPSG criteria.[8,12]
Another issue of  concern is whether too many women 
would get diagnosed as GDM because of  the low FPG 
cut-off  in the IADPSG criteria. Indeed, of  the 88 women 
who were diagnosed as GDM by virtue of  their FPG 
abnormality alone using IADPSG criteria, only 30 (34%) 
were classifi ed as GDM by the WHO criteria. A similar 
comparison with those with GDM according to the 
IADPSG 1-h cut-off  value showed that only 47/98 (48%) 
had GDM by WHO criteria. It is thus possible that by 
reducing the FPG cut-point to 92 mg/dl, we could be 
over-diagnosing GDM in normal pregnant women.[19] This 
could lead to overloading of  the health systems in many 
countries.[20,21]
We have earlier reported that the sensitivity of  the 2-h 
value in theglucose tolerance test (GTT) is much higher 
than the fasting plasma glucose among non-pregnant 
Indian adults.[22] Thus, it is reasonable to assume that since 
the IADPSG has raised the 2-h value in the IADPSG to 
153 mg/dl, many cases of  GDM could be missed.
One of  the limitations of  the study is that with our present 
data, we cannot conclude whether IADPSG or WHO 
criteria is better for Indian pregnant women as we do 
not have data on the maternal and fetal outcomes. In the 
absence of  the outcome data, which however, was beyond 
the purview of  the study, it was not possible to comment 
on the suitability of  diagnosing GDM by either of  the 
two criteria in this population. Nonetheless, this study 
compared the ease of  use of  two criteria in the population 
studied. Future studies should compare the outcomes of  
the GDM cases diagnosed by IADPSG and WHO criteria 
as this would provide the fi nal answer as to which criteria 
is more suitable for Indians.
The second limitation is that as the cases were selected 
from diabetes centers where women had been referred 
with suspected diabetes, this study cannot be used to study 
the prevalence rates of  GDM. This should be done in a 
maternity clinic or a general population where the entire 
population of  pregnant women is screened to study the 
prevalence rates of  GDM. This study however refl ects 
the usefulness of  the WHO and IADPSG criteria at a 
diabetes centers.
However, the strength of  the study is that it is the fi rst to our 
knowledge, to directly compare the IADPSG and the WHO 
criteria, especially in an Asian Indian population. Another 
strength is the relatively large numbers of  subjects studied.
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In summary, the WHO 2-h criteria of140 mg/dl alone 
appears to be suffi cient to diagnose GDM, as it picks up 
the majority of  GDM cases diagnosed by both the whole 
WHO criteria as well as the same number of  cases as 
the three sample IADPSG criteria. This could have great 
benefi t especially in rural areas in India where obtaining 
three blood samples as required by the IADPSG criteria, 
could be a major challenge.
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